BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is currently the most common bariatric procedure and results in a substantial weight loss and recovery from obesity-related comorbidities, both of which are maintained in the long term. However, besides the desired loss of fat mass, LRYGBP is also followed by the loss of fat-free mass (FFM). We aimed to determine the factors associated with the loss of ≥20 % of the initial FFM 1 year after LRYGBP in a prospective series of 115 Caucasian, premenopausal women. METHODS: Anthropometrics, body composition (bioelectrical impedance analysis), resting energy expenditure (REE) (indirect calorimetry), inflammation, insulin resistance, and lipid disturbances were determined before and 1 year after LRYGBP. RESULTS: The mean loss of initial FFM was 15.3 ± 13.8 %. 1 year after LRYGBP, 81 women lost <20 % (<20 % FFM group) and 35 lost ≥20 % (≥20 % FFM group) of the initial FFM. Before surgery, the FFM, weight, BMI, excess BMI, brachial circumference, waist circumference, and REE were significantly higher in the ≥20 % FFM group while inflammation, insulin resistance, and lipid disturbances were comparable between the two groups. 1 year after LRYGBP, the FFM, weight, BMI, excess BMI, brachial circumference, waist circumference, and REE decreased significantly and were comparable between the two groups. Inflammation, insulin resistance, and lipid disturbances improved comparably between the two groups after surgery. The only variable associated with the loss of ≥20 % of the initial FFM in the multivariable analysis was the presence of more FFM before surgery (67.0 ± 9.9 vs. 53.5 ± 6.7 kg). CONCLUSIONS: One year after LRYGBP the loss of ≥20 % of the initial FFM occurred mainly in women with more FFM before surgery and resulted in the same body composition of women who lost <20 % of the initial FFM.
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is currently the most common bariatric procedure and results in a substantial weight loss and recovery from obesity-related comorbidities, both of which are maintained in the long term. However, besides the desired loss of fat mass, LRYGBP is also followed by the loss of fat-free mass (FFM). We aimed to determine the factors associated with the loss of ≥20 % of the initial FFM 1 year after LRYGBP in a prospective series of 115 Caucasian, premenopausal women. METHODS: Anthropometrics, body composition (bioelectrical impedance analysis), resting energy expenditure (REE) (indirect calorimetry), inflammation, insulin resistance, and lipid disturbances were determined before and 1 year after LRYGBP. RESULTS: The mean loss of initial FFM was 15.3 ± 13.8 %. 1 year after LRYGBP, 81 women lost <20 % (<20 % FFM group) and 35 lost ≥20 % (≥20 % FFM group) of the initial FFM. Before surgery, the FFM, weight, BMI, excess BMI, brachial circumference, waist circumference, and REE were significantly higher in the ≥20 % FFM group while inflammation, insulin resistance, and lipid disturbances were comparable between the two groups. 1 year after LRYGBP, the FFM, weight, BMI, excess BMI, brachial circumference, waist circumference, and REE decreased significantly and were comparable between the two groups. Inflammation, insulin resistance, and lipid disturbances improved comparably between the two groups after surgery. The only variable associated with the loss of ≥20 % of the initial FFM in the multivariable analysis was the presence of more FFM before surgery (67.0 ± 9.9 vs. 53.5 ± 6.7 kg). CONCLUSIONS: One year after LRYGBP the loss of ≥20 % of the initial FFM occurred mainly in women with more FFM before surgery and resulted in the same body composition of women who lost <20 % of the initial FFM.
Authors: Sai Krupa Das; Susan B Roberts; Joseph J Kehayias; Jack Wang; L K George Hsu; Scott A Shikora; Edward Saltzman; Megan A McCrory Journal: Am J Physiol Endocrinol Metab Date: 2003-02-25 Impact factor: 4.310
Authors: Rebecca Thomson; Grant D Brinkworth; Jonathan D Buckley; Manny Noakes; Peter M Clifton Journal: Clin Nutr Date: 2007-10-23 Impact factor: 7.324
Authors: Torsten Olbers; Sofia Björkman; Ak Lindroos; Almantas Maleckas; Lars Lönn; Lars Sjöström; Hans Lönroth Journal: Ann Surg Date: 2006-11 Impact factor: 12.969
Authors: Ronenn Roubenoff; Helen Parise; Hélène A Payette; Leslie W Abad; Ralph D'Agostino; Paul F Jacques; Peter W F Wilson; Charles A Dinarello; Tamara B Harris Journal: Am J Med Date: 2003-10-15 Impact factor: 4.965
Authors: Cláudia S Minderico; Analiza M Silva; Kathleen Keller; Teresa L Branco; Sandra S Martins; António L Palmeira; José T Barata; Elvis A Carnero; Paulo M Rocha; Pedro J Teixeira; Luís B Sardinha Journal: Br J Nutr Date: 2007-09-26 Impact factor: 3.718
Authors: Rachel Galioto; Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad Journal: J Clin Exp Neuropsychol Date: 2015-04-15 Impact factor: 2.475
Authors: Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz Journal: Metabolism Date: 2017-02-02 Impact factor: 8.694
Authors: J Gómez-Ambrosi; P Andrada; V Valentí; F Rotellar; C Silva; V Catalán; A Rodríguez; B Ramírez; R Moncada; J Escalada; J Salvador; G Frühbeck Journal: Int J Obes (Lond) Date: 2017-06-06 Impact factor: 5.095
Authors: Daniel Berglind; Mikaela Willmer; Ulf Eriksson; Anders Thorell; Magnus Sundbom; Joanna Uddén; Mustafa Raoof; Jakob Hedberg; Per Tynelius; Erik Näslund; Finn Rasmussen Journal: Obes Surg Date: 2015-01 Impact factor: 4.129
Authors: Daniel Berglind; Mikaela Willmer; Per Tynelius; Ata Ghaderi; Erik Näslund; Finn Rasmussen Journal: Obes Surg Date: 2016-07 Impact factor: 4.129